Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
Miyashita Y, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K. Miyashita Y, et al. Among authors: yamaguchi t. J Atheroscler Thromb. 2009 Oct;16(5):621-6. doi: 10.5551/jat.497. J Atheroscler Thromb. 2009. PMID: 19907103 Free article. Clinical Trial.
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K. Sasaki H, et al. Among authors: yamaguchi t. J Atheroscler Thromb. 2009 Oct;16(5):568-75. doi: 10.5551/jat.1628. Epub 2009 Sep 14. J Atheroscler Thromb. 2009. PMID: 19749494 Free article. Clinical Trial.
Probucol suppresses initiation of chronic hemodialysis therapy and renal dysfunction-related death in diabetic nephropathy patients: Sakura study.
Endo K, Saiki A, Yamaguchi T, Sakuma K, Sasaki H, Ban N, Kawana H, Nagayama D, Nagumo A, Ohira M, Oyama T, Murano T, Miyashita Y, Yamamura S, Suzuki Y, Shirai K, Tatsuno I. Endo K, et al. Among authors: yamaguchi t. J Atheroscler Thromb. 2013;20(5):494-502. doi: 10.5551/jat.15263. Epub 2013 Jan 30. J Atheroscler Thromb. 2013. PMID: 23363981 Free article. Clinical Trial.
Effects of body weight reduction on cardio-ankle vascular index (CAVI).
Nagayama D, Endo K, Ohira M, Yamaguchi T, Ban N, Kawana H, Nagumo A, Saiki A, Oyama T, Miyashita Y, Shirai K. Nagayama D, et al. Among authors: yamaguchi t. Obes Res Clin Pract. 2013 Mar-Apr;7(2):e139-e145. doi: 10.1016/j.orcp.2011.08.154. Obes Res Clin Pract. 2013. PMID: 24331775 Clinical Trial.
The Role of a Novel Arterial Stiffness Parameter, Cardio-Ankle Vascular Index (CAVI), as a Surrogate Marker for Cardiovascular Diseases.
Saiki A, Sato Y, Watanabe R, Watanabe Y, Imamura H, Yamaguchi T, Ban N, Kawana H, Nagumo A, Nagayama D, Ohira M, Endo K, Tatsuno I. Saiki A, et al. Among authors: yamaguchi t. J Atheroscler Thromb. 2016;23(2):155-68. doi: 10.5551/jat.32797. Epub 2015 Nov 26. J Atheroscler Thromb. 2016. PMID: 26607350 Free article. Review.
Cardio-Ankle Vascular Index is Independently Associated with Future Cardiovascular Events in Outpatients with Metabolic Disorders.
Sato Y, Nagayama D, Saiki A, Watanabe R, Watanabe Y, Imamura H, Yamaguchi T, Ban N, Kawana H, Nagumo A, Ohira M, Endo K, Kurosu T, Tomaru T, Shirai K, Tatsuno I. Sato Y, et al. Among authors: yamaguchi t. J Atheroscler Thromb. 2016 May 2;23(5):596-605. doi: 10.5551/jat.31385. Epub 2015 Dec 2. J Atheroscler Thromb. 2016. PMID: 26632164 Free article.
9,367 results